Olaia Martí‐Marí

Statistics

Publications

Citations

113

H-Index

Active since

2019

Affiliations

Instituto de Química Médica(Current)

Rega Institute for Medical Research

KU Leuven

Universidad de Alcalá

Olaia Martí‐Marí is an author at Instituto de Química Médica specializing in medicinal chemistry, antiviral pharmacology, and antiviral structure-activity relationships.

ORCID

Publications per year

2019–2023

Publications

Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors

Belén Martínez-Gualda, Liang Sun, Olaia Martí‐Marí et al. · Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Multivalent Tryptophan‐ and Tyrosine‐Containing [60]Fullerene Hexa‐Adducts as Dual HIV and Enterovirus A71 Entry Inhibitors

Marta Ruiz‐Santaquiteria, Beatriz M. Illescas, Rana Abdelnabi et al. · Chemistry - A European Journal · 2021 · 16 citations · Full text

Life Sciences, Biology, Medicinal Chemistry +17

Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors

Olaia Martí‐Marí, Belén Martínez-Gualda, Sofía de la Puente-Secades et al. · Journal of Medicinal Chemistry · 2021 · 16 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15

Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum

Belén Martínez-Gualda, Liang Sun, Olaia Martí‐Marí et al. · Antiviral Research · 2019 · 14 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus Replication by Interfering with Viral Attachment Processes

Antonios Fikatas, Peter Vervaeke, Belén Martínez-Gualda et al. · Antimicrobial Agents and Chemotherapy · 2020 · 14 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

1–5 of 7